SFV MANUFACTURINGRecent and archived news stories on: Aerospace, Agribusiness, Chemicals, Electronics, Energy, Fabrication, Industrial, Plastics, Textiles...
Ceres Inc. has successfully petitioned to have genetic traits for corn deemed non-regulated, meaning those traits will not have to follow the same procedures outlined in the U.S. Department of Agriculture’s rules for genetically engineered crops, the company announced Wednesday.
New facility aims to let less go to waste
Impacts from Sun Valley’s new waste-processing plant.
Teledyne Technologies beat Wall Street estimates on revenue and earnings for the fourth quarter, the company announced Thursday.
Wesco Aircraft Holdings Inc. narrowly beat analyst expectations on adjusted earnings but fell short on matching revenue in the fiscal first quarter, it was announced Thursday.
Avery Dennison Corp. beat Wall Street expectations on adjusted earning and revenue for the fourth quarter, it was announced Wednesday.
Capstone Turbine Corp. beat analyst estimates on its earnings for the fiscal third quarter while just missing on revenue.
Ceres Inc. announced Friday that it has received an Australian patent for a gene that increases crop yields without increasing the need for fertilizer or other resources for growth.
MannKind Corp. announced Thursday that it has entered into a licensing agreement with newly formed pharmaceutical developer Receptor Life Sciences Inc. in Seattle to develop multiple inhaled therapeutic products for an array of conditions, including inflammatory disorders and neurological diseases.
Simulations Plus Inc. reported a 108 percent increase in net income and record revenue for its first fiscal quarter, which it partially attributed to its acquisition of Cognigen Corp.
Medtronic and IBM have joined forces to create an app using IBM’s supercomputer Watson, the former 2011 Jeopardy! champion that beat out two of the show’s greatest contestants.
Qualstar Corp. has received notification from the Nasdaq Capital Market that it was out of compliance for maintaining a minimum price on its shares.
MannKind Corp. announced Tuesday that Sanofi-Aventis U.S. has terminated its license and collaboration agreement to manufacture and market MannKind’s sole commercial product, Afrezza Inhalation Powder, a fast-acting inhalable insulin.
Amgen Inc. announced Monday that the European Commission has approved Imlygic, a first of its kind cancer drug, to treat adults with melanoma.
Simulations Plus Inc. announced a 17.6 percent increase in revenue in conjunction with its preliminary results for the fiscal first quarter of 2016 on Thursday.
LED technology company EcoSense Lighting in downtown L.A. announced on Monday that it has acquired the assets of Westlake Village’s Journée Lighting Inc.